Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Gene therapy Stories

Two Genetic Diseases Cured Through HIV
2013-07-12 05:01:10

[ Watch the Video: Gene Therapy Used By San Raffaele Telethon Institute For Gene Therapy ] redOrbit Staff & Wire Reports - Your Universe Online The virus that causes AIDS has been used to cure a pair of different genetic diseases, according to research published Thursday in the journal Science. In the studies, Luigi Naldini, director of the San Raffaele Telethon Institute for Gene Therapy (TIGET) in Italy, and his colleagues report they successfully used HIV to cure metachromatic...

2013-07-07 23:01:12

“Gene Therapy Partnering Terms and Agreements” is the new market research report added to ReportsnReports.com store. Dallas, Texas (PRWEB) July 07, 2013 The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the world's leading healthcare companies: Trends in gene therapy partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Gene therapy...

2013-06-17 08:27:34

MOUNTAIN VIEW, Calif., June 17, 2013 /PRNewswire/ -- In an effort to aid progress in gene therapy clinical research, representatives of Clontech laboratories, Inc. and its parent company Takara Bio Inc. announce the availability of clinical grade RetroNectin® reagent for direct supply to biomedical researchers. RetroNectin® reagent is designed to enable efficient retroviral transduction of genes into hematopoietic stem cells as well as lymphocytes and other blood cells. The...

2013-06-17 08:27:22

DUBLIN, June 17, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/dfcq6z/gene_therapy) has announced a new report "Gene Therapy - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/dfcq6z/gene_therapy ] to its offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for...

2013-06-16 23:00:52

A recent NBC News article highlights potential improvements that gene therapy can bring to plastic surgery. Dr. Simon Ourian of Epione Beverly Hills says that it may be years before practical applications are available. Los Angeles, California (PRWEB) June 16, 2013 According to a May 29, 2013 NBC News article, titled “Gene Therapies for Regenerative Surgery Are Getting Closer, Says Review in Plastic and Reconstructive Surgery,” researchers have made significant progress in the...

2013-06-13 10:02:38

Engineered virus will improve gene therapy for blinding eye diseases Researchers at the University of California, Berkeley, have developed an easier and more effective method for inserting genes into eye cells that could greatly expand gene therapy to help restore sight to patients with blinding diseases ranging from inherited defects like retinitis pigmentosa to degenerative illnesses of old age, such as macular degeneration. Unlike current treatments, the new procedure — which...

Promise In Duchenne Muscular Dystrophy Shown With Genetic Editing
2013-06-05 08:48:09

Duke University Using a novel genetic 'editing' technique, Duke University biomedical engineers have been able to repair a defect responsible for one of the most common inherited disorders, Duchenne muscular dystrophy, in cell samples from Duchenne patients. Instead of the common gene therapy approach of adding new genetic material to "override" the faulty gene, the Duke scientists have developed a way to change the existing mutated gene responsible for the disorder into a normally...

2013-05-30 23:00:55

Alex Brown and Erin Gillen join Kim Power Stilson on the TalkWorthy Radio Show to talk about the Utah Vision Walk. Blinding retinal degenerative diseases like retinitis pigmentosa, macular degeneration and Usher syndrome affect more than 10 million Americans, but the Foundation Fighting Blindness is funding cutting-edge studies toward preventions, treatments and cures. Salt Lake City, UT (PRWEB) May 30, 2013 Alex Brown and Erin Gillen, spokespersons for the 5th Annual Utah 5K VisionWalk on...

2013-05-21 08:29:26

AMSTERDAM, The Netherlands, May 21, 2013 /PRNewswire/ -- uniQure B.V., a leader in the field of human gene therapy, today announced that with its consortium partners it is to receive a EUR 2.5 million Eurostars grant to develop an RNA interference (RNAi) gene therapy for Huntington's disease. The consortium is a pan-European collaboration consisting of uniQure as the coordinator, Lausanne University Hospital, Switzerland, University Medical Center Gottingen, Germany, and Maria...

2013-05-21 08:28:22

Clinical Data on CERE-120 (AAV-NRTN) Presented at the 16th Annual Meeting of the American Society of Gene and Cellular Therapy (ASGCT) SAN DIEGO, May 21, 2013 /PRNewswire/ -- Ceregene, Inc. today announced additional efficacy data from a secondary analysis of its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin). CERE-120 is a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease. This exploratory...